Background: Diabetes is one of the most common chronic diseases in which antioxidant capacity changes. Omega-3 fatty acids have extensive biological effects including their advantage on lipoprotein metabolism, platelet function, cytokine production, clotting, fibrinolysis, and inflammatory factors. This study aimed to investigate the effect of omega-3 fatty acid supplements on antioxidant capacity in patients with type 2 diabetes.
INTRODUCTION
Diabetes is a relatively prevalent disease that occurs as a result of lack or dysfunction of insulin. [1] Approximately 6% American have different levels of glucose metabolism disorder, which indicate diabetes or the tendency to have diabetes. [2] According to WHO, the prevalence of type 2 diabetes was estimated to be 5.5, 5.7, and 6.8% in 1995, 2000, and 2005, respectively. [3] Stephens et al. studied the biological relationship and measured plasma markers of oxidative stress in diabetic and cardiovascular patients and found a close relationship between diabetes mellitus and increased oxidative stress.
Adiposity and a longer duration of obesity are important risks factors for type 2 diabetes, and even little weight losses are associated with a maodulataion of hyperglycemia in persons with prediabetes. [5] Review studies have shown that the level of free radicals increases and the level of antioxidants decreases during diabetes. [6] Linoleic acid (omega-6) and Linolenic acid (omega-3) have important roles in body functions, but they cannot be produced in the absence or lack of an enzyme. [7] Mori et al. [7] studied the effect of EPA, DHA, and olive oil on oxidative stress and biochemical parameters of patients with type 2 diabetes and found that EPA and DHA reduce oxidative stress without changing inflammatory markers in patients with type 2 diabetes. [7] Thorsdottir et al., [8] from Iceland concluded that omega-3 fatty acids in milk reduces type 2 diabetes in men. [8] Lean et al. [9] concluded that omega-3 fatty acids significantly reduce serum lipids and control serum sugar in patients with type 2 diabetes. [9] With regard to high prevalence and irreparable complications of diabetes, there is probable role of free radicals in the developmentand progress of the disease as well as the fact that omega-3 fatty acids have extensive biological effects on lipoprotein metabolism, platelet function, cytokine production, clotting, fibrinolysis, and inflammatory factors. [7] Hajianfar et al. found that omega-3 reduced weight in the case group that used omega-3 vs. control group. [10] This study aimed to investigate the effect of omega-3 fatty acid supplement on antioxidant capacity of patients with type 2 diabetes.
METHODS
This study was a double-blind randomized placebo controlled clinical trial. The study population consisted of 45-65 year-old women with type 2 diabetes admitted to Shariaty Clinic in Isfahan. Considering the extra 15%, sample size in each group was estimated 39 people.
Thirty-seven volunteers were recruited in the case group and 34 entered the placebo group after signing the informed written consent form. Inclusion criteria were type 2 diabetes for at least 5 years, no insulin shot, no secondary complications of diabetes such as ophthalmologic complications, renal complications, amputation, renal diseases, blindness, cardiovascular diseases, and no high CRP.
At the beginning of study, demoghraphic characteristics were gathered by questionnaire. Blood sampling was done after 10-12 hrs fasting. Biochemical indices including serum antioxidant capacity and HbA1c were measured. Then, the subjects received supplement or placebo according to the groups for 8 weeks. At the end of study, we measured anthropometric and biochemical indices again.
Anthropometrical measurements
A digital scale (seca) was used to measure weight with an accuracy of +100g. Subjects were weighed without shoes and light clothing. Height was measured without shoes to the nearest 0.5 cm with the use of a commercial stadiometer with the shoulders in relaxed position and arms hanging freely. Body mass index (BMI) was calculated by dividing weight (kg) by height (m 2 ). Both the lab technician and the patients were unaware of the intervention. Data were analyzed using SPSS 18 software, and tables and charts were drawn. Fisher's exact test was used for qualitative information, t test was used for quantitative test, Chi square test was used for weight changes, and Pearson's correlation test was used for data correlation. Changes between two groups were compared using independent t test. Pearson's regression was used to find relationship between variables.
Findings
The results showed that the omega-3 group and placebo group were not significantly different in terms of age, education, and occupation. Furthermore, other variables like comorbid diseases, medication, and diet were not significantly different between the two groups. Therefore, they cannot be considered confounding factor is this study.
Mean age of patients was 53.6 ± 4.3 and 53.9 ± 5.4 in the case and control groups, respectively. According to t test, no significant difference was found between the two groups in this regard (P = 0.79). Mean of serum age, BMI, weight, HbA1c concentration and antioxidant capacity and comparison of the changes before and after intervention at two groups is showen in Table 1 and 2.
DISCUSSION
The main objective of this study was to determine the effect of omega-3 supplement on antioxidant capacity of patients with diabetes type 2. The results show that taking omega-3 supplement increases antioxidant capacity and reduces HbA1c in patients with type 2 diabetes. This finding shows the role of omega-3 supplement in controlling HbA1c, which is a criterion to evaluate the control level of serum glucose in diabetes. This finding is in agreement with that of other studies. [11] Omega-3 consumption reduced HbA1c in diabetic patients, [12, 13] but this change was not significant in Kesuvalu's study. [14] Several studies confirm the results of this study about increase in antioxidant capacity after taking omega-3 supplement. Suresh et al., [15] concluded that omega-3 can improve oxidative stress in diabetes, which corresponds with the result of the present study. Mori et al., [7] found that EPA and DHA reduced oxidative stress in type 2 diabetes. This finding is against that of some studies by Fokine et al., [16] Samaoui et al., [17] studied the relationship between fat in diet and antioxidants in diabetic patients and found that antioxidant capacity in diabetic patients who did not control diabetes well was reduced. Blaszzak et al. [18] reported an increase in antioxidant capacity of diabetic patients, which is in line with our findings. Pasaogala et al., (2004) found that the level of oxidative stress in patients with type 2 diabetes was higher than that in the control group. The amount of free radicals in patients with type 2 diabetes increases and antioxidant resistance reduces, therefore oxidative stress increases in such people. [19] Kasuvalu showed that omega-3 reduced free radicals and increased antioxidant enzymes in this group, [14] which is in line with our finding. Antioxidants reduce in these patients because increased free radicals cause different diseases including diabetes, and weaken antioxidant system. Tayyebi-Khosroshahi [20] concluded that omega-3 in hemodialysis patients increased antioxidant factors like glutathione peroxide and superoxide mutase Hiratsuka [21] found that DHA rich diet has antioxidant activity in rat's brain. Omega-3 reduces triglyceride and oxidative stress. [22] This study resulted in the following, aiming to investigate the effect of omega-3 supplement on antioxidant capacity of patients with type 2 diabetes. HbA1c and antioxidant capacity in these people were significant, indicating that the intervention was useful and increased antioxidant capacity in these people. Considering the probable role of antioxidant system in causing type 2 diabetes, we can prevent type 2 diabetes in healthy people and reduce diabetes complications and its progress by boosting their antioxidant defense system.
CONCLUSIONS
Some studies found a significant relationship between the level of serum visfatin and BMI of the participants. [23] [24] [25] [26] This finding is against the findings of Pagano et al., [27] on fat non-diabetic patients and that of Samara et al., [28] on non-diabetic people with different weights; they found an inverse relationship between BMI and Visfatin. Furthermore, Chen et al., [29] found a significant relationship between serum visfatin and BMI in patients with type 2 diabetes.
Recommendation
Since weakening of antioxidant system can cause diabetes and because findings of the present study showed that omega-3 supplement can 
